|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Current status in remnant gastric cancer after distal gastrectomy显示文摘Remnant gastric cancer(RGC) and gastric stump cancer after distal gastrectomy(DG) are recognized as the same clinical entity. In this review, the current knowledges as well as the non-settled issues of RGC are presented. Duodenogastric reflux and denervation of the gastric mucosa are considered as the two main factors responsible for the development of RGC after benign disease. On the other hand, some precancerous circumstances which already have existed at the time of initial surgery, such as atrophic gastritis and intestinal metaplasia, are the main factors associated with RGC after gastric cancer. Although eradication of Helicobacter pylori(H. pylori) in remnant stomach is promising, it is still uncertain whether it can reduce the risk of carcinogenesis. Periodic endoscopic surveillance after DG was reported useful in detecting RGC at an early stage, which offers a chance to undergo minimally invasive endoscopic treatment or laparoscopic surgery and leads to an improved prognosis in RGC patients. Future challenges may be expected to elucidate the benefit of eradication of H. pylori in the remnant stomach if it could reduce the risk for RGC, to build an optimal endoscopic surveillance strategy after DG by stratifying the risk for development of RGC, and to develop a specific staging system for RGC for the standardization of the treatment by prospecting the prognosis. | Masaichi Ohira Takahiro Toyokawa Katsunobu Sakurai Naoshi Kubo Hiroaki Tanaka Kazuya Muguruma Masakazu Yashiro Naoyoshi Onoda Kosei Hirakawa | 2016 | World Journal of Gastroenterology2016，22，8： | 15 |
| 2 | Vitamin D receptor expression is associated with colon cancer in ulcerativecolitis显示文摘 | Koji Wada Hiroaki Tanaka Kiyoshi Maeda Toru Inoue Eiji Noda Ryosuke Amano Naoshi Kubo Kazuya Muguruma Nobuya Yamada Masakazu Yashiro Tetsuji Sawada Bunzo Nakata Masaichi Ohira Kosei Hirakawa | 2009 | Oncology Reports2009，，5： | 2 |
| 3 | Renal angiomyolipoma: relationships between tumor size, aneurysm formation, andrupture 显示文摘 | Koichiro Yamakado Naoshi Tanaka Toshio Nakagawa | 2002 | Radiology2002，225，： | 1 |
| 4 | Letter to the Editor Re: Transjugular Intrahepatic Portosystemic Shunt for Intractable Esophageal-Gastric Variceal Hemorrhage in a Patient with Idiopathic Myelofibrosis显示文摘 | Naoshi Tanaka M.D. Koichiro Yamakado M.D. Hisakazu Kihira M.D. Akira Hashimoto M.D. Takashi Murayama M.D. Kan Takeda M.D | 2000 | CardioVascular and Interventional Radiology2000，，6： | 1 |
| 5 | Superselective Bronchial Artery Embolization for Hemoptysis with a Coaxial Microcatheter System显示文摘 | Naoshi Tanaka Koichiro Yamakado Shuichi Murashima Kan Takeda Kaname Matsumura Tsuyoshi Nakagawa Katsuhiro Takano Mototsugu Ono Takao Hattori | 1997 | Journal of Vascular and Interventional Radiology1997，，1： | 1 |
| 6 | Role of the Stemness Factors Sox2, Oct3/4, and Nanog in Gastric Carcinoma显示文摘 | Junko Matsuoka Masakazu Yashiro Katsunobu Sakurai Naoshi Kubo Hiroaki Tanaka Kazuya Muguruma Tetsuji Sawada Masaichi Ohira Kosei Hirakawa | 2012 | Journal of Surgical Research2012，，1： | 1 |
| 7 | Renal angiomyolipoma: relationships between tumor size, aneurysm formation, and rupture 显示文摘 | Koichiro Yamakado Naoshi Tanaka Toshio Nakagawa | 2002 | Radiology2002，225，： | 1 |
| 8 | Clinical efficacy of portal vein stent placement in patients with hepatocellular carcinoma invading the main portal vein显示文摘 | Koichiro Yamakado Naoshi Tanaka Atsuhiro Nakatsuka Kaname Matsumura Kojiro Takase Kan Takeda | 1999 | Journal of Hepatology1999，，4： | 1 |
| 9 | Role of the Stemness Factors Sox2, Oct3/4, and Nanog in Gastric Carcinoma显示文摘 | Junko Matsuoka Masakazu Yashiro Katsunobu Sakurai Naoshi Kubo Hiroaki Tanaka Kazuya Muguruma Tetsuji Sawada Masaichi Ohira Kosei Hirakawa | 2012 | Journal of Surgical Research2012，，1： | 1 |
| 10 | Role of the Stemness Factors Sox2, Oct3/4, and Nanog in Gastric Carcinoma显示文摘 | Junko Matsuoka Masakazu Yashiro Katsunobu Sakurai Naoshi Kubo Hiroaki Tanaka Kazuya Muguruma Tetsuji Sawada Masaichi Ohira Kosei Hirakawa | 2012 | Journal of Surgical Research2012，，1： | 1 |
| 11 | Role of the Stemness Factors Sox2, Oct3/4, and Nanog in Gastric Carcinoma显示文摘 | Junko Matsuoka Masakazu Yashiro Katsunobu Sakurai Naoshi Kubo Hiroaki Tanaka Kazuya Muguruma Tetsuji Sawada Masaichi Ohira Kosei Hirakawa | 2012 | Journal of Surgical Research2012，，1： | 1 |
| 12 | Fracture of ossified Achilles tendons:A review of cases显示文摘Fracture of an ossification of the Achilles tendon(OAT)is a rare entity,and its etiology,pathology,and treatment remain unclear.We reviewed and scrutinized 18 cases(16 articles)of the fracture of an OAT.The most common etiologies of the ossifications include previous surgery and trauma.The fractures often occur without any trigger or with minimal trigger.The long,>5 cm,ossification in the body of the Achilles tendon may have a higher risk of fracture.The OAT itself is often asymptomatic;however,its fracture causes severe local pain,swelling,and weakness of plantar flexion,which forces patients to undergo aggressive treatments.Regarding the treatments of the fractures,nonoperative treatment by immobilizing ankle joint could be an option for elderly patients.However,because it often cannot produce satisfactory results in younger patients,surgical treatment is typically recommended.Excision of the fractured mass and repairing the tendon is applicable if the remnant is enough.If there is a defect after the excision,reconstruction with autologous grafts or adjacent tendon transfer is performed.Gastrocnemius fascia turndown flap,hamstring tendon and tensor fascia lata are used as autologous grafts,whereas peroneus brevis and flexor hallucis longus tendons are used for the tendon transfer.If the fracture of an OAT is treated properly,the functional result will be satisfactory. | Hisatoshi Ishikura Naoshi Fukui Mitsuyasu Iwasawa Satoru Ohashi Takeyuki Tanaka Sakae Tanaka | 2021 | World Journal of Orthopedics2021，12，4： | 1 |
| 13 | Impact of peginterferon alpha‐2b and entecavir hydrate combination therapy on persistent viral suppression in patients with chronic hepatitis B显示文摘 | Satoru Hagiwara Masatoshi Kudo Yukio Osaki Hiroo Matsuo Tadashi Inuzuka Akihiro Matsumoto Eiji Tanaka Toshiharu Sakurai Kazuomi Ueshima Tatsuo Inoue Norihisa Yada Naoshi Nishida | 2013 | Virol2013，，6： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员